{"version":"1.0","provider_name":"T2S Group","provider_url":"https:\/\/t2s.group\/en","author_name":"Admin T2s","author_url":"https:\/\/t2s.group\/en\/author\/admin-t2s\/","title":"MEDRAD\u00ae Mark 7 Arterion - T2S Group","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"wBVSOhxL4E\"><a href=\"https:\/\/t2s.group\/en\/produit\/medrad-mark-7-arterion\/\">MEDRAD\u00ae Mark 7 Arterion<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/t2s.group\/en\/produit\/medrad-mark-7-arterion\/embed\/#?secret=wBVSOhxL4E\" width=\"600\" height=\"338\" title=\"&#8220;MEDRAD\u00ae Mark 7 Arterion&#8221; &#8212; T2S Group\" data-secret=\"wBVSOhxL4E\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/t2s.group\/en\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/t2s.group\/en\/wp-content\/uploads\/2024\/06\/MEDRAD\u00ae-Mark-7-Arterion.jpg","thumbnail_width":225,"thumbnail_height":225,"description":"MEDRAD\u00ae Mark 7 Arterion est un syst\u00e8me d'injection \u00e0 t\u00eate unique pour l\u2019angiographie par rayons X, con\u00e7u pour les salles de radiologie interventionnelle de pointe. Il permet l\u2019injection contr\u00f4l\u00e9e de produit de contraste radio-opaque pour les besoins de l'imagerie interventionnelle en radiologie interventionnelle, cardiologie interventionnelle et chirurgie vasculaire. L\u2019injecteur facilite l\u2019administration du produit de contraste sous forme de d\u00e9bit fixe ou de d\u00e9bit variable gr\u00e2ce \u00e0 une mise \u00e0 niveau logicielle optionnelle. Il utilise une seringue sp\u00e9ciale de 150 ml (\u00e0 chargement avant) et peut d\u00e9livrer le produit de contraste en mode progressif."}